https://www.ouhealth.com/stephenson-cancer-center/cancer-treatments/chemotherapy-infusion/
Explore Chemotherapy at Stephenson Cancer Center. We offer an in-person Chemo 101 class two times per month. This class is offered the first Thursday of the month from 10 - 11 a.m. and the third Thursday of the month at 2 - 3 p.m. Classes are held in room 6012 at OU Health Stephenson Cancer Center.

https://www.youtube.com/watch?v=qgnSZgbLWew
We offer an in-person Chemo 101 class two times per month. This class is offered the first Thursday of the month from 10 - 11 a.m. and the third Thursday of

https://www.ouhealth.com/documents/content/SCC_201201_Booklet_PreparingforChemo_-2254_EF_PROOF.pdf
sults to the cancer center at (405) 271-2491. If you would like your labs drawn at Stephenson Cancer Center, the second floor lab welcomes walks-ins: Lab, Floor 2 OU Health Stephenson Cancer Center Monday - Friday, 7 a.m. - 5:30 p.m. If you have a port, your labs will need to be drawn at the infusion center. Please call

https://www.ouhealth.com/stephenson-cancer-center/cancer-patients-families/cancer-supportive-care/cancer-education-workshops/
Get information about cancer education workshops and cancer treatments from your care team at OU Health Stephenson Cancer Center in Oklahoma City. ... chemotherapy, one of the most common cancer treatments. Chemo 101 helps you and your caregivers learn what to expect and how to prepare for treatment. ... Chemo 101 video or download and view our

https://intranet.stephensoncancercenter.org/Portals/1051/Assets/Preparing%20for%20Chemotherapy.pdf
for IV Chemotherapy at the cancer center. It provides helpful patient information, guidelines and rules for the infusion center, and tips for caregivers. Patient Touchpoint: This packet should be given at the time of the Chemotherapy Consent. Patients should also be encouraged to attend Chemo 101, or watch the video on the website.

https://sccnew.ouhsc.edu/Portals/1283a/Assets/Handbook_Sheets_Web.pdf
Trust, the Stephenson Cancer Center is decreasing the burden of cancer in Oklahoma by supporting innovative laboratory, clinical and populations-based research. The Stephenson Cancer Center has 250 research members who are conducting more than 215 cancer research projects at institutions across Oklahoma. This research is supported

https://www.ou.edu/news/articles/2023/august/ou-health-stephenson-cancer-center-phase-1-clinical-trial-drug-approved-by-the-fda
OKLAHOMA CITY — A drug tested at OU Health Stephenson Cancer Center was recently approved by the FDA, providing new and improved treatment options for patients with platinum resistant ovarian cancer for the first time in nearly a decade.. Mirvetuximab soravtansine (Elahere) received accelerated FDA approval in November 2022, for patients with ovarian cancer whose tumors are resistant to

https://www.ou.edu/news/articles/2024/february/exposure-to-secondhand-smoke-decreases-effectiveness-of-chemotherapy-ou-health-sciences-research-reveals-in-first-of-its-kind-study
If they are exposed to secondhand smoke during chemotherapy — even if they have never smoked themselves — the treatment may be far less effective at killing cancer cells. That finding, considered the first of its kind, was revealed in a study recently published by researchers at the University of Oklahoma Health Sciences.

https://www.ouhsc.edu/News/details/stephenson-cancer-center-researcher-leads-global-trial-for-promising-new-drug-for-ovarian-cancer
Results of a global clinical trial published recently in The New England Journal of Medicine show that a new drug significantly improves survival in women with epithelial ovarian cancer, a deadly gynecologic cancer that often becomes resistant to chemotherapy. The lead author of the study is Kathleen Moore, M.D., associate director of clinical research at OU Health Stephenson Cancer Center at

https://www.ouhsc.edu/News/details/ArtMID/37278/ArticleID/34578/OU-Health-Stephenson-Cancer-Center-Top-5-Enroller-in-Trial-Testing-CAR-T-cell-Therapy-as-Earlier-Treatment-for-Aggressive-Lymphoma
OKLAHOMA CITY — CAR T-cell therapy — a treatment in which a patient's own immune cells are genetically modified to recognize and attack cancerous cells — is revolutionizing the care of people diagnosed with blood cancers. OU Health Stephenson Cancer Center at the University of Oklahoma Health Sciences Center took part in a global clinical trial that led to a change in the way

https://www.ou.edu/news/articles/impact
OU Health Stephenson Cancer Center at Norman Regional will Bring Research-driven Cancer Care to More Oklahomans OU Health Stephenson Cancer Center and Norman Regional Health System celebrated a Topping Out Ceremony for the new cancer care facility on the Norman Regional HealthPlex campus, marking a significant milestone in the construction project and offering the community a first look at the

https://www.ouhealth.com/stephenson-cancer-center/
Research & Innovation. Stephenson Cancer Center serves as a transformative research hub for advancing cancer care. You can access early-phase clinical trials and therapies through research that brings the latest breakthroughs in science to your care plan. Investigators currently work on more than 400 cancer research projects, supported by $60

https://www.ouhsc.edu/News/details/stephenson-cancer-center-to-offer-new-immune-therapy-car-t-1
OKLAHOMA CITY - A revolutionary new treatment that harnesses the body's own immune cells to fight tumors will be offered at the Stephenson Cancer Center at OU Medicine, beginning June 13. Called CAR T-cell therapy, the treatment has been approved by the Food and Drug Administration and will be offered in Oklahoma only at the Stephenson

https://www.koco.com/article/oklahoma-ou-health-researchers-ovarian-cancer-treatment/46464827
OU Health announced Friday that researchers at the Stephenson Cancer Center are playing a major role in making a new, more effective treatment available to patients dealing with reoccurring - sometimes chemo-resistant - ovarian cancer. The team at OU Health recently wrapped up phase three trials for the drug, MIRV. >> Download the KOCO 5 App.

https://news.ouhsc.edu/Article/patients-over-80-benefit-from-immunotherapy-for-certain-cancers-according-to-international-study-co-led-by-ou-health-stephenson-cancer-center-physician
OU Health Stephenson Cancer Center was named Oklahoma's top facility for cancer care by U.S. News & World Report in its 2020-21 rankings. As Oklahoma's only National Cancer Institute-Designated Cancer Center, Stephenson Cancer Center is one of the nation's elite centers, representing the top 2% of cancer centers in the country.

https://doctor.webmd.com/practice/ou-health-stephenson-cancer-center-16023569-66e3-4daa-8827-b1aa858b618b/physicians
Ou Health Stephenson Cancer Center. Claim your practice. 15 Specialties 49 Practicing Physicians. (1) Write A Review. Ou Health Stephenson Cancer Center. 800 NE 10th St Fl 6 Oklahoma City, OK 73104. (405) 271-4022. OVERVIEW.

https://www.ouhealth.com/stephenson-cancer-center/cancer-patients-families/plan-your-visit-or-appointment/
Plan ahead with simple steps to make the most of your appointment or visit at OU Health Stephenson Cancer Center in Oklahoma City. ... July 04 10:00am - 11:00am Chemo 101. We offer an in-person Chemo 101 class two times per month. This class is offered the first Thursday of

https://www.utmedicalcenter.org/treatments/melanoma-and-soft-tissue-cancer
Please call 865-305-6278 for more information. The Melanoma and Soft Tissue Tumor (MASTT) Service at The University of Tennessee Medical Center Cancer Institute specializes in the treatment of skin cancers and soft tissue tumors such as: We offer comprehensive treatment of both benign and malignant soft tissue tumors (sarcomas).

https://www.ouhsc.edu/News/details/stephenson-cancer-center-developing-app-for-cancer-patients-during-covid-19
An oncologist and a mobile health researcher at Stephenson Cancer Center at OU Medicine are creating an app that will monitor the well-being of patients with cancer during the time of COVID-19. The National Cancer Institute funded a grant for the rapid creation of the app and a study on its effectiveness. Stephenson Cancer Center plans to enroll 500 patients who are receiving chemotherapy for

https://www.utmedicalcenter.org/locations/university-cancer-specialists
University Cancer Specialists. • Main Campus. Address. 1926 Alcoa Hwy. Building F, Suite 210 (2nd Floor) and Suite 410 (4th Floor) Knoxville, TN 37920. Phone. 865-305-8780. Fax.

https://www.ouhealth.com/stephenson-cancer-center/cancer-treatments/
Depending on your specific situation, you and your Stephenson Cancer Center care team may choose from innovative, evidence-based cancer treatments such as: Chemotherapy and infusion - Medications designed to destroy cancer cells; often used in combination with other therapies, including surgery, to remove any traces of cancer after a

https://www.utmedicalcenter.org/locations/university-cancer-specialists-sevierville
University Cancer Specialists - Lenoir City 5779 Creekwood Park Blvd, Lenoir City, TN 37772 Phone: 865-458-3926

https://www.ouhealth.com/find-a-location/ou-health-stephenson-cancer-center/
OU Health Stephenson Cancer Center. Handicap Access OU Health Stephenson Cancer Center. 800 NE 10th St. Oklahoma City, OK 73104. Get Directions Phone: (405) 271-1112 Toll Free: 855-750-2273. Social:

https://www.utmedicalcenter.org/treatments/medical-oncology
7326 Maynardville Pike. Knoxville, TN 37938. Phone: 865-305-8780. University Cancer Specialists - Halls. Hanna Cancer Associates - Turkey Creek. Physicians Plaza. Knoxville, TN 37934. Phone: (865) 544-9171. Hanna Cancer Associates - Turkey Creek.